Recombinant Oligopeptide transport system permease protein AmiD (amiD)

Shipped with Ice Packs
In Stock

Description

Role of AmiD in the Ami Permease System

The Ami permease system comprises:

  • AmiC and AmiD: Transmembrane proteins forming a selective channel for oligopeptide translocation .

  • AmiE and AmiF: Cytosolic ATPases energizing transport via ATP hydrolysis .

  • Oligopeptide-binding proteins (OBPs): Lipoproteins (e.g., AmiA, AliA, AliB, AliC, AliD) that capture extracellular peptides .

AmiD partners with AmiC to create a substrate-specific channel, ensuring only compatible oligopeptides enter the cytoplasm. This system overcomes pneumococcal auxotrophies and facilitates competition in polymicrobial environments .

Mechanism of Oligopeptide Transport

  1. Substrate binding: OBPs (e.g., AliD) capture peptides via a conserved binding pocket, inducing a closed conformation .

  2. Channel gating: Peptide delivery to AmiC/AmiD triggers ATP hydrolysis by AmiE/AmiF, powering substrate translocation .

  3. Structural dynamics: Molecular dynamics simulations suggest that AmiD undergoes rigid-body rotations to align with OBPs, ensuring efficient peptide transfer .

Key residues in AmiD’s transmembrane helices likely mediate interactions with OBPs and regulate channel permeability, though exact motifs require further mutagenesis studies .

Research Findings and Functional Implications

  • Genetic essentiality: In S. pneumoniae, the amiD gene is co-expressed with amiC in a single operon, and its deletion disrupts oligopeptide uptake, impairing growth in peptide-limited environments .

  • Environmental sensing: Non-encapsulated pneumococcal strains employ AmiD to detect peptides from competing bacteria, modulating virulence gene expression .

  • Structural models: Cryo-EM and crystallography of recombinant AliD (a homologous OBP) reveal how conserved residues in AmiD may coordinate peptide recognition and transport .

Unresolved Questions and Future Directions

  • Substrate specificity: What structural features of AmiD dictate its interaction with diverse OBPs?

  • Regulatory role: Does AmiD directly influence transcriptional responses to environmental peptides?

  • Therapeutic targeting: Can AmiD inhibition block pneumococcal virulence without disrupting commensal bacteria?

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format we have in stock. However, if you have specific format requirements, please indicate them during order placement, and we will fulfill your request.
Lead Time
Delivery time may vary depending on the purchasing method and location. Please contact your local distributor for specific delivery timelines.
Note: All our proteins are shipped with standard blue ice packs. If you require dry ice shipping, please inform us in advance, as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial prior to opening to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final concentration of glycerol is 50%, which can serve as a reference.
Shelf Life
Shelf life is influenced by various factors, including storage conditions, buffer components, temperature, and the inherent stability of the protein.
Generally, the shelf life of the liquid form is 6 months at -20°C/-80°C. The shelf life of the lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during the production process. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
amiD; SP_1889; Oligopeptide transport system permease protein AmiD
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-308
Protein Length
full length protein
Species
Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)
Target Names
amiD
Target Protein Sequence
MSTIDKEKFQFVKRDDFASETIDAPAYSYWKSVFKQFMKKKSTVVMLGILVAIILISFIY PMFSKFDFNDVSKVNDFSVRYIKPNAEHWFGTDSNGKSLFDGVWFGARNSILISVIATVI NLVIGVFVGGIWGISKSVDRVMMEVYNVISNIPPLLIVIVLTYSIGAGFWNLIFAMSVTT WIGIAFMIRVQILRYRDLEYNLASRTLGTPTLKIVAKNIMPQLVSVIVTTMTQMLPSFIS YEAFLSFFGLGLPITVPSLGRLISDYSQNVTTNAYLFWIPLTTLVLVSLSLFVVGQNLAD ASDPRTHR
Uniprot No.

Target Background

Function
AmiD is a component of the binding-protein-dependent transport system for oligopeptides. It is likely responsible for the translocation of the substrate across the membrane.
Database Links

KEGG: spn:SP_1889

Protein Families
Binding-protein-dependent transport system permease family, OppBC subfamily
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is Oligopeptide transport system permease protein AmiD and what is its function?

The Oligopeptide transport system permease protein AmiD (amiD) is a membrane protein component of the Ami ABC transporter system in Streptococcus pneumoniae. This 308-amino acid protein (UniProt ID: P0A4M9) serves as part of the membrane channel that facilitates oligopeptide transport across the bacterial cell membrane . AmiD functions within a complex system comprising five exposed Oligopeptide Binding Proteins (OBPs) and four proteins that collectively form the ABC transporter channel . The entire system is responsible for importing oligopeptides from the extracellular environment into the bacterial cytoplasm, where they can be broken down into amino acids essential for bacterial survival and growth.

How is recombinant AmiD typically produced for research purposes?

Recombinant AmiD is typically produced using an E. coli expression system with an N-terminal His-tag to facilitate purification. The methodological approach involves:

  • Cloning the full-length AmiD gene (spanning amino acids 1-308) into an appropriate expression vector

  • Transforming the construct into E. coli

  • Inducing protein expression under optimized conditions

  • Harvesting cells and lysing to release the expressed protein

  • Purifying using immobilized metal affinity chromatography (IMAC) to capture the His-tagged protein

  • Additional purification steps as needed to achieve >90% purity (as determined by SDS-PAGE)

  • Formulating in a Tris/PBS-based buffer with 6% Trehalose, pH 8.0

The purified protein is typically provided as a lyophilized powder and should be reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL. For long-term storage, it is recommended to add 5-50% glycerol (final concentration) and store in aliquots at -20°C/-80°C to avoid repeated freeze-thaw cycles .

What structural features characterize AmiD and how do they relate to its function?

AmiD's amino acid sequence (MSTIDKEKFQFVKRDDFASETIDAPAYSYWKSVFKQFMKKKSTVVMLGILVAIILISFIYPMFSKFDFNDVSKVNDFSVRYIKPNAEHWFGTDSNGKSLFDGVWFGARNSILISVIATVVINLVIGVFVGGIWGISKSVDRVMMEVYNVISNIPPLLIVIVLTYSIGAGFWNLIFAMSVTTWIGIAFMIRVQILRYRDLEYNLASRTLGTPTLKIVAKNIMPQLVSVIVTTMTQMLPSFISYEAFLSFFGLGLPITVPSLGRLISDYSQNVTTNAYLFWIPLTTLVLVSLSLFVVGQNLADASDPRTHR) reveals key structural elements that contribute to its function as a permease component :

  • Transmembrane domains: Multiple hydrophobic regions that span the cell membrane

  • Channel-forming regions: Structured to allow oligopeptide passage

  • Interaction interfaces: Domains that interact with other components of the ABC transporter complex

  • Substrate recognition sites: Regions involved in oligopeptide binding and translocation

The protein's structure is engineered for its role in the transmembrane translocation of oligopeptides, with conformational changes occurring during the transport cycle that facilitate substrate movement across the membrane barrier .

How does AmiD interact with other components of the Ami ABC transporter system?

The complete Ami transport system comprises multiple proteins working in concert to achieve oligopeptide transport. Based on structural analyses, a model has been proposed for how AmiD integrates with other system components :

  • Oligopeptide Binding Proteins (OBPs) initially capture peptides from the extracellular environment

  • The peptide-loaded OBPs interact with the permease components (including AmiD) at the membrane interface

  • This interaction triggers conformational changes in the permease proteins

  • ATP hydrolysis by the nucleotide-binding domains provides energy for transport

  • Conformational changes in AmiD and other membrane components facilitate oligopeptide translocation into the cytoplasm

These interactions involve specific protein-protein interfaces that allow for productive engagement while maintaining transport specificity. The structural analysis reveals essential conformational changes that occur during this process, providing insights into the molecular mechanism of oligopeptide transport .

What is known about the substrate specificity of the Ami system and AmiD's role in this specificity?

Research on the Ami system has revealed interesting aspects of substrate specificity:

  • The OBPs in the system demonstrate remarkable promiscuity, with affinity for a wide range of peptides when expressed in E. coli

  • Mass spectrometry analysis has confirmed the diversity of oligopeptides bound by these proteins

  • Multiple crystallographic structures, capturing both open and closed conformations along with complexes involving chemically synthesized peptides, have been solved at high resolution

AmiD, as a permease component, likely contributes to selectivity during the membrane translocation phase. The structural analysis of the entire Ami system provides valuable insights into the mechanism and specificity of oligopeptide binding and transport, with AmiD playing a crucial role in the transmembrane movement of these substrates .

What are the optimal methods for studying AmiD-substrate interactions?

Studying AmiD-substrate interactions requires a multi-faceted experimental approach:

  • Binding Assays:

    • Isothermal Titration Calorimetry (ITC) to measure binding thermodynamics

    • Surface Plasmon Resonance (SPR) for real-time binding kinetics

    • Fluorescence-based assays using labeled oligopeptides

  • Structural Studies:

    • X-ray crystallography of AmiD in different conformational states

    • Cryo-electron microscopy for visualizing the transport complex

    • NMR spectroscopy for dynamic information in solution

  • Functional Assays:

    • Reconstitution into proteoliposomes for transport studies

    • ATPase activity measurements to correlate substrate binding with energy utilization

    • Fluorescently labeled oligopeptides to track transport

  • Mutagenesis Approaches:

    • Alanine scanning to identify critical residues

    • Site-directed mutagenesis based on structural predictions

    • Domain swapping to map specificity-determining regions

The combination of these methods provides complementary information about AmiD's role in oligopeptide recognition and transport, offering a comprehensive understanding of the molecular mechanisms involved.

What challenges are associated with AmiD expression and purification, and how can they be addressed?

Working with membrane proteins like AmiD presents several challenges:

ChallengeMethodological Solution
Low expression levelsOptimize codon usage, use specialized host strains (C41/C43), test different promoters
Protein insolubilityExpress with fusion partners (MBP, SUMO), use mild detergents for extraction
Aggregation during purificationIncorporate stabilizing agents (glycerol, specific lipids), optimize buffer conditions
Loss of structural integrityValidate functional state using binding or ATPase assays after purification
Difficulty in crystallizationUse antibody fragments or nanobodies to stabilize specific conformations
Storage instabilityLyophilize with stabilizers like trehalose, avoid repeated freeze-thaw cycles

The recombinant His-tagged AmiD protein should be stored in appropriate buffer conditions (Tris/PBS-based buffer with 6% Trehalose, pH 8.0), and repeated freeze-thaw cycles should be avoided . Working aliquots can be stored at 4°C for up to one week, while long-term storage requires -20°C/-80°C conditions .

How can researchers establish functional assays for AmiD-mediated oligopeptide transport?

Developing functional assays for AmiD-mediated transport requires careful experimental design:

  • Reconstitution Systems:

    • Proteoliposomes: Incorporate purified AmiD (and other Ami components) into artificial liposomes

    • Nanodiscs: Use membrane scaffold proteins to create defined membrane environments

    • Whole-cell systems: Express AmiD in transport-deficient bacterial strains

  • Transport Detection Methods:

    • Fluorescently labeled oligopeptides to track movement across membranes

    • Radiolabeled substrates for quantitative transport measurements

    • pH-sensitive fluorophores to detect coupled ion movements

  • Energy Coupling Assessment:

    • ATP hydrolysis assays to correlate energy utilization with transport

    • Membrane potential measurements to assess electrogenic aspects of transport

    • Proton flux measurements to detect secondary coupling mechanisms

  • Data Analysis Approaches:

    • Kinetic modeling to extract transport parameters (Km, Vmax)

    • Comparison of different substrates to establish specificity profiles

    • Correlation of structural data with transport efficiency

These methodological approaches allow researchers to establish robust functional assays that provide insights into the mechanism of AmiD-mediated oligopeptide transport across membranes.

How do conformational changes in AmiD contribute to the transport mechanism?

Understanding conformational dynamics is crucial for elucidating AmiD's transport mechanism:

  • Observed Conformational States:

    • Multiple crystallographic structures have captured both open and closed conformations of components in the Ami system

    • These structures reveal significant conformational changes associated with substrate binding

  • Mechanistic Implications:

    • The alternating access model likely applies, where AmiD alternates between outward-facing and inward-facing states

    • Substrate binding triggers conformational changes that facilitate oligopeptide translocation

    • ATP binding and hydrolysis drive these conformational rearrangements

  • Experimental Approaches for Studying Conformational Changes:

    • FRET measurements between strategically placed fluorophores

    • Hydrogen-deuterium exchange mass spectrometry to identify regions with altered solvent accessibility

    • EPR spectroscopy with site-directed spin labeling to measure distance changes

    • Molecular dynamics simulations to model conformational transitions

These conformational changes are essential structural elements facilitating oligopeptide transport into the cellular cytoplasm, as disclosed in structural analyses of the Ami system .

What is known about the evolutionary conservation of AmiD across different bacterial species?

Evolutionary analysis of AmiD provides insights into its functional importance:

  • Conservation Patterns:

    • Core functional domains tend to be highly conserved across different bacterial species

    • Regions involved in interactions with other Ami components show strong conservation

    • Substrate-binding regions may exhibit more variability, reflecting different nutrient requirements

  • Phylogenetic Distribution:

    • AmiD homologs are found across various bacterial species, particularly in Gram-positive bacteria

    • The entire Ami system architecture is maintained in many streptococcal species

    • Selective pressure has maintained the functional integrity of this transport system

  • Functional Implications:

    • High conservation suggests essential roles in bacterial physiology

    • Species-specific variations may reflect adaptation to different nutrient environments

    • Potential as a broad-spectrum antimicrobial target due to its conserved nature

Understanding this evolutionary context provides valuable insights into AmiD's fundamental importance in bacterial physiology and its potential as a therapeutic target.

How might inhibition of AmiD affect bacterial viability and virulence?

The potential of AmiD as a therapeutic target warrants consideration:

These insights suggest that AmiD and the broader Ami system represent promising targets for novel antimicrobial strategies.

What are the key parameters for evaluating AmiD transport activity?

Quantitative assessment of AmiD transport function involves several key parameters:

ParameterDescriptionMeasurement Method
Transport Rate (Vmax)Maximum velocity of oligopeptide transportTransport assays with varying substrate concentrations
Substrate Affinity (Km)Concentration at half-maximal transport rateKinetic analysis of transport data
Substrate SpecificityRange of oligopeptides transportedComparative transport assays with different peptides
Energy Coupling EfficiencyATP molecules hydrolyzed per peptide transportedSimultaneous measurement of ATP hydrolysis and transport
Temperature DependenceEffect of temperature on transport activityTransport assays at different temperatures
pH DependenceEffect of pH on transport activityTransport assays at different pH values

These parameters provide a comprehensive profile of AmiD's transport characteristics and can be used to compare wild-type and mutant proteins or assess the effects of potential inhibitors.

How can researchers distinguish between direct effects on AmiD and indirect effects on the Ami system?

Distinguishing direct from indirect effects requires careful experimental design:

  • Isolated Component Studies:

    • Purify AmiD alone to study direct binding and conformational changes

    • Reconstitute AmiD with individual system components to assess specific interactions

    • Compare with complete system reconstitution to identify emergent properties

  • Mutagenesis Approaches:

    • Engineer mutations specifically in AmiD interaction interfaces

    • Create chimeric proteins by swapping domains between AmiD and other permeases

    • Use complementation studies in knockout strains to validate functional roles

  • Comparative Analysis:

    • Monitor effects of interventions on multiple Ami system components

    • Establish cause-effect relationships through time-course experiments

    • Correlate structural perturbations with functional outcomes

  • Mathematical Modeling:

    • Develop kinetic models incorporating all system components

    • Simulate the effects of perturbations at different points in the system

    • Validate model predictions with experimental data

What are the most common pitfalls in AmiD research and how can they be avoided?

Research on membrane proteins like AmiD presents several challenges:

Common PitfallPreventive Strategy
Protein misfolding during recombinant expressionOptimize expression conditions, use mild detergents, validate structural integrity
Artifact formation in detergent environmentsCompare results across different membrane mimetics, validate with functional assays
Non-specific binding in interaction studiesInclude appropriate controls, validate with multiple binding assays
Incomplete reconstitution of the transport systemVerify incorporation of all components, check stoichiometry, validate with functional assays
Misinterpretation of indirect effectsUse isolated component studies, establish clear cause-effect relationships
Overlooking conformational heterogeneityEmploy techniques that can detect and analyze multiple conformational states

Awareness of these potential pitfalls and implementation of appropriate control experiments and validation strategies can significantly enhance the reliability and relevance of AmiD research findings.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.